Spiraea formosana HAYATA is an endemic shrub of Rosaceae distributed widely in high altitudes of forests in central Taiwan. 1) The young leaves, fruits and roots of Spiraea species have been used as diuretic, detoxicant, and analgesic agents and for the treatment of inflammation, cough, headache and toothache in traditional Chinese medicine.
Some of Spiraea species reported to exhibit potent antiplatelet aggregation activities induced by PAF and AA, 6) and also inhibition of generation of nitric oxide and superoxide in RAW 264.7 cells. 7, 8) Several Spiraea species of Japan origin were reported to have high allelopathic potential. 9) Plants in this genus are known to produce various diterpene alkaloids of atisine and hetisine types, [10] [11] [12] [13] [14] [15] [16] [17] and some of them significantly inhibited rabbit platelet aggregation induced by PAF and AA in vitro and ex vivo. 6) Some of these diterpene alkaloids also exhibited protective effects on cerebral ischemia-reperfusion injury in gerbils.
18 ) The members of Spiraea are also shown to contain benzaldehydes, cinnamoyl glucosides, flavonoids, terpenoids and terpenoid glycosides. [19] [20] [21] [22] [23] An acetylated derivative of a unique terpene glycoside, prunioside A from Spiraea species is reported to inhibit nitric oxide production in murine macrophage-like RAW 264.7 cells. 24) However, little is known concerning the chemical constituents of S. formosana. As a part of serial studies on the Formosan endemic plants, we have undertaken the investigation of the chemical components of the stems of S. formosana and isolated thirty nine compounds including four new neolignans. Details of the isolation and structural determination of new neolignans (1) (2) (3) (4) are presented here.
Results and Discussion
Fresh stems of S. formosana were extracted with hot ethanol. The water suspension of the original ethanol extract was subjected to a liquid-liquid partition to obtain CHCl 3 , nBuOH and water subfractions. Four new biphenyl ether neolignans together with thirty five known compounds were separated from these subfractions by a combination of chromatographic techniques. New neolignans were characterized as dimers of trans-4-hydroxycinnamic acid, an important lignin precursor, which were isolated for the first time from the natural sources. However, Katase et 35 .9 (C-8Ј), 51.9 (OCH 3 -10Ј) and 173.5 (C-9Ј)] as evidenced by HMBCs from H-7Ј to C-2Ј, C-1Ј, and C-9Ј. These data indicated the presence of a second phenylpropanoyl moiety leading to 1 being a neolignan. These two moieties were connected with ether linkage was suggested by the molecular formula and the two oxygenated quaternary aromatic carbons at d 144.6 (C-4Ј) and 149.4 (C-3). The negative Gibb's test for compound 1 indicated that the para-position of free hydroxyl group was substituted with the olefinic fragment, so that C-3 should be involved in ether linkage. To further confirm the position of free hydroxyl group and thus the site of ether linkage, compound 1 was methylated with iodomethane in acetone solution. The resulting compound exhibited one more methoxy group at d 3.67 (3H, s). This methoxy signal displayed NOESY correlation with the proton signal at d 7.03 (H-5) 29, 2004 confirmed that the free hydroxyl group was located at C-4 and thus carbons C-3 and C-4Ј were involved in the ether linkage between two phenylpropanoid moieties. Accordingly 1 was confirmed to be a new neolignan 3-p-methyldihydrocoumaroyloxy methyl-p-coumarate and assigned the trivial name spiraformin A.
New Neolignans from Spiraea formosana
The second lignan, compound 2 was isolated as a colorless syrup. It has the molecular formula of C 21 H 22 O 6 based on
HR-EI-MS analysis ([M]
ϩ , m/z 370.1414) which was 14 mass units more than that of 1. The UV absorption maxima and IR absorption bands of 2 were similar to those in 1 at 230 and 285 nm, and 3374 and 1723 cm Ϫ1 , respectively, indicated that 2 has similar basic skeleton and functionalities. Analysis of the 1 H-NMR data showed that 2 had spectral data very similar to those of 1, indicating a close structural relationship. In the 1 H-NMR spectrum of 1 and 2 the evident difference between them the signal of one methoxy group was changed to an ethoxy group [d 1.25 (3H, t, Jϭ7.2 Hz, CH 3 -11Ј) and 4.13 (2H, q, Jϭ7.2 Hz, CH 2 -10Ј)]. The observation of 3 J-correlation between CH 2 -10Ј (d 4.13) and C-9Ј (d 173.5) in the HMBC spectrum of 2 confirmed the connection of the ethoxy group with C-9Ј of dihydrocoumaroyl moiety. Thus, 2 was determined to be 3-p-ethyldihydrocoumaroyloxy methyl-p-coumarate and was assigned the trivial name spiraformin B.
Spiraformin C (3) a colorless syrup had a molecular formula of C 23 
H 26 O 6 as determined by HR-EI-MS ([M]
ϩ , m/z 398.1731). The UV and IR spectra of 3 were also similar with those of 1. Its NMR spectral data was very similar to those of 1 indicating the same basic skeleton for 3. However, in compound 3, a set of signals for n-butyloxy group was found at d 0.92 (3H, t, Jϭ7.4 Hz, CH 3 -13Ј), 1.55 (2H, m, CH 2 -12Ј), 1.61 (2H, m, CH 2 -11Ј), and 4.09 (2H, t, Jϭ6.8 Hz, CH 2 -10Ј) instead of a methoxy signal. The evident difference in the molecular formula and the NMR signals between 3 and 1 concluded that one methyl ester group was changed to n-butyl ester group in 3. The HMBC correlations of methylene protons at d 4.09 (CH 2 -10Ј) with C-9Ј (d 175.4) and CH 3 -10 (d 3.75) with C-9 (d 170.3) confirmed that the nbutyl ester was connected with C-9Ј. Thus the structure of 3 was assumed to be 3-p-n-butyldihydrocoumaroyloxy methylp-coumarate and named as spiraformin C. In addition, spiraeaine A (5), 27) b-sitosterol (6), 27) bakuchiol (7), 27) glutinol (8), 27) b-amyrin (9), 23) b-sitosterone (10), 28) mixture of b-sitosterol (6) and stigmasterol (11), 27) methyl vanillate (12), 29) methyl ferulate (13), 30) ethyl p-hydroxy-trans-cinnamate (14), 31) ethyl ferulate (15), 32) agrimonolide (16), 33) aurantiamide acetate (17), 34) b-sitosteryl glucoside (18), 27) nonadecyl ferulate (19), 27) nonadecyl-3-(4-hydroxyphenyl)propionate (20) , 35) uridine (21), 36) 3-O-b-Dglucoside-p-vanillic acid (22) , 37) vanillic acid (23), 26) p-hydroxybenzoic acid (24) , 38) veratric acid (25), 38) syringic acid (26), 39) 3-O-b-D-glucoside-4Ј,5-dihydroxystilbene (27), 40) p-hydroxybenzaldehyde (28), 27) 42) p-coumaric acid (34), 42) 3,4Ј,5-trihydroxystilbene (35), 26) p-hydroxycinnamaldehyde (36), 43) quercetin (37), 42) (ϩ)-5,7-dihydroxy-2-(3Ј,4Ј-methylenedioxyphenyl)chroman-4-one (38), 44) and N,N-dimethyladenine (39) 45) were also identified by comparison of their physical and spectral data with those reported in the literature.
Experimentaøl
General Experimental Methods Melting points were measured on Yanaco MP-S3 micro-melting point apparatus and uncorrected. 1 H-and 13 C-NMR spectra were obtained on the Bruker Avance-300 and AMX-400 NMR spectrometers, with tetramethylsilane (TMS) as internal standard. IR spectra were determined as KBr discs on a Shimadzu FTIR-8501 spectrophotometer, and UV spectra were recorded in MeOH on a Hitachi UV-3210 spectrophotometer. EI-and HR-EI-MS were measured with a 70 eV direct inlet system on a VG 70-250S spectrometer, and the FAB-and HR-FAB-MS were obtained on a Jeol JMS-700 spectrometer. Optical rotations were determined on a Jasco DIP-370 digital polarimeter.
Plant Material Stems of S. formosana was collected in Ilan Hsien, Taiwan, Republic of China, in 1991. A voucher specimen (Wu 1991010 ) is deposited in the Herbarium of National Cheng Kung University, Tainan, Taiwan.
Extraction and Isolation The fresh stem (8.6 kg) of S. formosana was powdered and extracted with hot EtOH (10 Lϫ7). The combined extracts were concentrated to give dark brown syrup (1.01 kg) and it was partitioned with CHCl 3 and n-BuOH, successively, to afford four individual portions: CHCl 3 layer (320 g), n-BuOH layer (220 g), H 2 O layer (290 g), and residue (180 g). The condensed CHCl 3 solubles were subjected to alkaloids extraction using 3% HOAc and 5% NH 4 OH to yield a crude alkaloid extract (9.2 g). It was chromatographed over silica gel and with a gradient of CHCl 3 and MeOH to afford 6 fractions. Fraction 5 was further purified by HPLC [Cosmosil 5C-18-AR-II Waters (5 mm)] with MeOH-H 2 O (60 : 40) to give 5 (5.7 mg). The non-alkaloidal fraction was chromatographed on silica gel by eluting with gradient of n-hexane and EtOAc, to give 10 fractions. Fraction 2 was subjected to chromatography on a silica gel column with n-hexane and C 6 H 6 (19 : 1) eluent followed by recrystallization of a subfraction obtained to give 6 (7.2 g). Fraction 3 was repeatedly column chromatographed over silica gel with n-hexane and CHCl 3 (9 : 1) to yield 7 (16.2 mg) and 8 (3.8 g). Recrystallization of fourth fraction with C 6 H 6 afforded 9 (5.8 g). Fraction 5 on a silica gel column chromatography with a gradient of n-hexane and (CH 3 ) 2 CO afforded 10 (23.7 mg) and a mixture of 6 and 11 (4.8 g). Silica gel column chromatography of fraction 6 and followed by PTLC purification with the mixture of n-hexane and (CH 3 ) 2 CO (5 : 1) resulted in 3 (1.3 mg), 12 (13.6 mg), 13 (17.4 mg), 14 (47.6 mg), and 15 (67.8 mg). Fraction 7 on a silica gel column chromatography with C 6 H 6 and (CH 3 ) 2 CO (19 : 1) followed by purification of subfractions 2 and 3 by PTLC with n-hexane and (CH 3 ) 2 CO (19 : 1) afforded 1 (9.8 mg) and 2 (1.1 mg). Purification of fraction 8 and 9 by repeated silica gel column chromatography using C 6 
